The hemp movement for investors is about more than just CBD oil and legal joints. It’s about products that you may take for granted in terms of market positioning, such as beverages, sweeteners, skin creams, and supplements.
Basically, ProductX that everyone has might be improved by being ProductX+Cannabinoid. Research is starting to show the possibility that many products will be healthier and less dangerous if cannabinoids are part of the equation. That has started to seep into the broad zeitgeist and have an impact.
With that in mind, we take a look at a few of the more active and interesting stocks with direct exposure to theme, including: Medical Marijuana Inc (OTCMKTS:MJNA), Neptune Wellness Solutions Inc (NASDAQ:NEPT), Cannabis Global Inc (OTCMKTS:CBGL), and cbdMD Inc (NYSEAMERICAN:YCBD).
Medical Marijuana Inc (OTCMKTS:MJNA) operates in the medical marijuana and industrial hemp markets. Its products range from patented and proprietary based cannabinoid products to seed and stalk or isolated high value extracts manufactured and formulated for the pharmaceutical, nutraceutical, and cosmeceutical industries.
The company licenses its proprietary testing, genetics, labeling and packaging, tracking, production, and standardization methods for the medicinal cannabinoid industry.
Medical Marijuana Inc (OTCMKTS:MJNA) recently announced that the Japanese division of its subsidiary Kannaway® had its best month ever in Company history in July 2020.
“Kannaway has made tremendous progress around the world as consumers in Japan and across Asia continue to show an exciting increase in interest for cannabidiol (CBD) products,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “Our team has truly shown what can be accomplished with passion, hard work and high-quality products designed to support the body’s crucial endocannabinoid system.”
The context for this announcement is a bit of a bid, with shares acting well over the past five days, up about 0% in that timeframe.
Medical Marijuana Inc (OTCMKTS:MJNA) managed to rope in revenues totaling $11M in overall sales during the company’s most recently reported quarterly financial data — a figure that represents a rate of top line growth of -46.9%, as compared to year-ago data in comparable terms. In addition, the company is battling some balance sheet hurdles, with cash levels struggling to keep up with current liabilities ($5M against $10.5M, respectively).
Neptune Wellness Solutions Inc (NASDAQ:NEPT) operates through two segments, Nutraceutical and Cannabis. The Nutraceutical segment offers turnkey solutions, such as raw material sourcing, formulation, quality control, and quality assurance for omega-3 and hemp-derived ingredients under different delivery forms, including softgels, capsules, and liquids. The Cannabis segment provides extraction and purification services from cannabis and hemp biomass.
The company also offers formulation and manufacturing solutions for value added product forms, such as tinctures, sprays, topicals, vapor products, edibles, and beverages.
Neptune Wellness Solutions Inc (NASDAQ:NEPT) just announced its proprietary Mood Ring cannabis brand for the Canadian market. The Mood Ring brand and product line will officially launch in select Canadian markets this fall to meet consumer demand for high-quality, affordable and environmentally friendly cannabis products.
Mood Ring leverages Neptune’s decades of experience in the wellness, extraction and consumer packaged goods (CPG) industries to bring product offerings to market that are designed to meet the specific demands of Canadian consumers. Mood Ring CBD products primarily target wellness-focused consumers looking for natural products, whereas Mood Ring THC concentrates focus on the recreational market.
The stock has suffered a bit of late, with shares of NEPT taking a hit in recent action, down about -6% over the past week.
Neptune Wellness Solutions Inc (NASDAQ:NEPT) managed to rope in revenues totaling $21.4M in overall sales during the company’s most recently reported quarterly financial data — a figure that represents a rate of top line growth of 389.9%, as compared to year-ago data in comparable terms. In addition, the company has a strong balance sheet, with cash levels far exceeding current liabilities ($25.5M against $22.9M).
Cannabis Global Inc (OTCMKTS:CBGL) continues to make progress on the strategy of converting its stockpile of R&D IP into commercialized products with growing interest.
This includes beverages, a range of CBD products, explorations into exotic cannabinoids, and its line of Hemp You Can Feel™ products, which now include both alcohol substitute cocktail mixers and a range of infused sweeteners.
Cannabis Global Inc (OTCMKTS:CBGL) just put out an interesting release launching what it calls the “Hemp You Can Feel™ Challenge”, which involves making available free samples of its new honeybee-powered water soluble hemp extract sweetener line are now available.
This pairs with another key move made recently by the company into the alcohol substitute mixing space. According to its recent release, Hemp You Can Feel™ mixers are now available for online consumer purchase as well as bulk purchase for wholesale distribution. Cocktails based on the Hemp You Can Feel™ mixers provide an experience on par with light alcohol consumption, but without any of the harmful side effects of alcohol.
The Sweetener move is particularly interesting given the huge $58 billion addressable market in that sector.
“What will you find by taking the Hemp You Can Feel™ Challenge? – Probably the best hemp infusion technology on the market today,” commented Arman Tabatabaei, CEO of Cannabis Global. “Where most hemp extracts and CBD products rely on chemicals to suspend the cannabinoids in foods and beverages, our products do this naturally, powered by the advanced and patented Bee-Fuse Technology™ and Hemp You Can Feel™ technology. With no added chemicals, no bitter taste, and no clouded beverages, it is simply the best hemp infusion technology available. We invite you to try our sweetener line for free, and hope you will tell us about your experiences.”
And the stock has been acting well over recent days, up something like 4% in that time.
Cannabis Global Inc (OTCMKTS:CBGL) just cracked the surface on commercial-stage operations in its last quarterly update. And, given the strong R&D foundation, we could imagine big things ahead if it executes on its current strategy.
cbdMD Inc (NYSEAMERICAN:YCBD) promulgates itself as a company that produces and distributes various cannibidiol (CBD) products. It owns and operates the consumer hemp-based CBD brand, cbdMD. The company’s product categories include CBD tinctures, capsules, gummies, bath bombs, topical creams, and animal treats and oils. It also offers pet related CBD products under the Paw CBD brand name.
The company distributes its products through an e-commerce Website, wholesalers, and various brick and mortar retailers in the United States.
cbdMD Inc (NYSEAMERICAN:YCBD) just announced that the company was proud to support MMA champion Daniel “DC” Cormier, a premier member of “Team cbdMD”, which is the CBD industry’s premier athletic sponsorship program, as he prepares for the fight of his career. This past Saturday, August 15, 2020, Cormier headlined a primetime MMA showdown against heavyweight champ Stipe Miocic in a highly anticipated ‘rubber match’. ‘Miocic vs. Cormier 3’ aired live at 10 PM ET (ESPN+ PPV) from the UFC APEX facility in Las Vegas.
“My mind is ready, and my body is ready to do something great. This fight is the build-up of years of hard work and preparation. Thousands of hours on the mat and endless amounts of time training. This fight means everything to me, literally everything. And I am so thankful for cbdMD and put my trust in their CBD ‘Recover’ Inflammation Cream, CBD bath bombs, and CBD gummies to help me get ready for this major fight,” said Cormier.
The context for this announcement is a bit of a bid, with shares acting well over the past five days, up about 3% in that timeframe.
cbdMD Inc (NYSEAMERICAN:YCBD) managed to rope in revenues totaling $10.6M in overall sales during the company’s most recently reported quarterly financial data — a figure that represents a rate of top line growth of 32.2%, as compared to year-ago data in comparable terms. In addition, the company has a strong balance sheet, with cash levels far exceeding current liabilities ($15.1M against $4.4M).
COMPENSATION DISCLOSURE: Section 17(b) of the 1933 Act requires publishers to disclose who paid them, the amount, and the type of payment. In order to be in full compliance with the Securities Act of 1933, Section 17(b): Tiger Global Management Partners LLC has compensated a third party to produce and present weekly content for various companies for the publication. For more information, please click here. In addition, this article is part of JournalTranscript.com Networks. Read the JournalTranscript.com Networks Disclaimer.
